How precision medicine, immunotherapy are influencing clinical trial design for cancer drugs – MedCity News
MedCity News |
How precision medicine, immunotherapy are influencing clinical trial design for cancer drugs
MedCity News Newfound understanding of the biology of cancer has spurred a wave of oncology drug approvals, creating previously unheard of treatment success. At the same time, this degree of success leads to a rapidly shifting competitive landscape, presenting … |
